PETS Petmed Express Inc
Price (delayed)
$3.5
Market cap
$72.3M
P/E Ratio
350
Dividend/share
N/A
EPS
$0.01
Enterprise value
$23.3M
Founded in 1996, PetMed Express is America's Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct
Highlights
The company's net income has surged by 137% QoQ and by 113% YoY
Petmed Express's EPS has surged by 117% QoQ and by 108% YoY
PETS's gross profit is down by 12% year-on-year and by 4.2% since the previous quarter
The revenue has contracted by 11% YoY and by 4.8% from the previous quarter
Key stats
What are the main financial stats of PETS
Market
Valuations
Earnings
Shares outstanding
20.66M
Market cap
$72.3M
Enterprise value
$23.3M
Price to earnings (P/E)
350
Price to book (P/B)
0.75
Price to sales (P/S)
0.29
EV/EBIT
16.6
EV/EBITDA
2.82
EV/Sales
0.09
Revenue
$247.01M
Gross profit
$68.37M
Operating income
$655,000
Net income
$357,000
EBIT
$1.4M
EBITDA
$8.26M
Free cash flow
$855,000
Per share
Balance sheet
Liquidity
EPS
$0.01
EPS diluted
$0.01
Free cash flow per share
$0.04
Book value per share
$4.65
Revenue per share
$11.97
TBVPS
$5
Total assets
$144.8M
Total liabilities
$48.61M
Debt
$1.11M
Equity
$96.18M
Working capital
$20.42M
Debt to equity
0.01
Current ratio
1.43
Quick ratio
1.09
Net debt/EBITDA
-5.93
Margins
Efficiency
Dividend
EBITDA margin
3.3%
Gross margin
27.7%
Net margin
0.1%
Operating margin
0.3%
Return on assets
0.2%
Return on equity
0.4%
Return on invested capital
31%
Return on capital employed
1.4%
Return on sales
0.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PETS stock price
How has the Petmed Express stock price performed over time
Intraday
-0.57%
1 week
13.27%
1 month
-14.43%
1 year
-13.58%
YTD
-27.39%
QTD
-16.47%
Financial performance
How have Petmed Express's revenue and profit performed over time
Revenue
$247.01M
Gross profit
$68.37M
Operating income
$655,000
Net income
$357,000
Gross margin
27.7%
Net margin
0.1%
The company's operating margin has surged by 138% QoQ and by 119% YoY
The company's net income has surged by 137% QoQ and by 113% YoY
The operating income has soared by 133% from the previous quarter and by 114% YoY
PETS's net margin has surged by 125% since the previous quarter and by 110% year-on-year
Growth
What is Petmed Express's growth rate over time
Valuation
What is Petmed Express stock price valuation
P/E
350
P/B
0.75
P/S
0.29
EV/EBIT
16.6
EV/EBITDA
2.82
EV/Sales
0.09
Petmed Express's EPS has surged by 117% QoQ and by 108% YoY
The price to book (P/B) is 76% lower than the 5-year quarterly average of 3.1 and 17% lower than the last 4 quarters average of 0.9
The equity has declined by 3.9% year-on-year
The P/S is 79% below the 5-year quarterly average of 1.4 and 3.3% below the last 4 quarters average of 0.3
The revenue has contracted by 11% YoY and by 4.8% from the previous quarter
Efficiency
How efficient is Petmed Express business performance
Petmed Express's return on sales has surged by 160% YoY
PETS's ROE has soared by 140% from the previous quarter and by 116% YoY
The company's return on assets has surged by 133% QoQ and by 113% YoY
Dividends
What is PETS's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Petmed Express financials performed over time
Petmed Express's total assets is 198% more than its total liabilities
The quick ratio has soared by 54% YoY
The company's total liabilities fell by 34% YoY
PETS's debt is 99% smaller than its equity
The company's debt to equity has shrunk by 50% YoY
PETS's debt is down by 33% year-on-year and by 9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.